Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
296 participants
INTERVENTIONAL
2016-10-31
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study
NCT03742011
OVERWEIGHT AND OBESITY ADVERSELY AFFECT IVF OUTCOMES IN WOMEN WITH PCOS
NCT03120286
Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
NCT04264832
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
NCT01482286
Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome
NCT06545721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our hypothesis is that intensive lifestyle intervention in overweight/obese pregnant women with PCOS will decrease GWG and reduce the incidence of GDM.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lifestyle intervention
Intervention group: Intensive lifestyle intervention will be initiated from the first trimester (8-12wks) to delivery, with follow up every 2-4 weeks. Participants in the intervention group will be provided with an individualized dietary protocol with not less than 1500 calories per day in the first trimester and not less than 1800 calories per day after 13 weeks of gestation. Guidance on regular exercise is reinforced at the first and each follow up visit.
Intensive Lifestyle Intervention
Dietary intervention combined with healthy lifestyle counseling
Standard Care
Standard care group: Participants will receive a 1.5-hour group session in which standard prenatal intervention on diet, nutrition and physical activity and recommendation for gestational weight gain are reviewed by a registered dietitian. Thereafter, participants will receive their regularly scheduled follow up visits without additional lifestyle guidance.
Standard Care
Standard prenatal care on diet, nutrition and physical activity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive Lifestyle Intervention
Dietary intervention combined with healthy lifestyle counseling
Standard Care
Standard prenatal care on diet, nutrition and physical activity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥18 years, and a singleton pregnancy.
Exclusion Criteria
* gestational weeks ≥ 13
* age \<18 years
* multiple pregnancy
* uterine malformation
* or physical restriction that prevents exercise.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guanghui Li
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guanghui Li, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Beijing Obstetrics and Gynecology Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Obstetrics and Gynecology Hospital,Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z16110700050000
Identifier Type: OTHER
Identifier Source: secondary_id
Z161100000516160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.